An interventional study of 17% EDTA and 9% HEDP-NaOCl in Chronic Apical Periodontitis, sponsored by Cukurova University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Cukurova University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 81 studies in Periapical Periodontitis with a site in Turkey — 13 open to participants now, 20 under way, none of them phase 3. Periapical Periodontitis · Turkey.
Among the 81 studies in Periapical Periodontitis with a site in Turkey, this one is the 12th largest by enrollment of the 75 interventional ones that give a count, is one of 15 that started in 2025, is one of 73 with no phase, and was the 81st registered.
281 studies on the registry are indexed under Periapical Periodontitis; 79 are open to participants now.
Browse Periapical Periodontitis studies →13 of the 81 studies in Periapical Periodontitis with a site in Turkey are open now. Recruiting first, the newest first:
Karadeniz Technical University · Sites in Turkey
Ages 18–65
Alanya Alaaddin Keykubat University · Sites in Turkey
Ages 18–70
Medipol University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Mustafa Kemal University · Sites in Turkey
Ages 18–60 · Healthy volunteers
ESRA DAĞCI · Sites in Turkey
Ages 18+ · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 43 Periapical Periodontitis studies recruiting now, 17 (40%) set no upper age limit and 25 (58%) stop at 75 or younger; 5 take children under 18; 21 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
81 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 15 started in 2025.
This study's enrollment of 132 is above the median of 60 across 246 interventional studies indexed under Periapical Periodontitis.
Median enrollment 66 across the 75 interventional studies, 60 across the 6 observational. Of the 60 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 81 have an industry lead sponsor. The 10 most frequent:
Cukurova University is the lead sponsor of 261 studies on the registry; 48 are open to participants now.
Cukurova University has 2 studies filed under Periapical Periodontitis — fewer than ten, so there is no comparison to draw.
7 of the studies in Periapical Periodontitis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07867314Recep Tayyip Erdogan UniversityEffect of Apical Patency on Periapical Lesion Healing | 2026-11-27 |
| NCT07850895Recep Tayyip Erdogan UniversityEffects of Irrigation Activation Methods on Periapical Healing in Chronic Apical Periodontitis | 2026-12 |
| NCT07921277Karadeniz Technical UniversityEffects of Different Activation Techniques on Antimicrobial Photodynamic Therapy in Apical Periodontitis | 2026-12-30 |
| NCT07714733Alanya Alaaddin Keykubat UniversityEffect of Different Apical Motion Algorithms on Postoperative Pain After Root Canal Treatment | 2027-03-15 |
| NCT07353008Mustafa Kemal UniversityEffect of Different Chelation Protocols on the Healing of Periapical Lesions in Teeth With Chronic Apical Periodontitis | 2027-04 |
Add all 7 to your calendar (.ics) → With an account.
Among the 81 studies in Periapical Periodontitis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this randomized controlled clinical trial is to evaluate the effects of different concentrations of etidronic acid (HEDP) combined with sodium hypochlorite (NaOCl), with or without EDDY sonic activation, on postoperative pain and 12-month clinical and radiographic outcomes in adults undergoing single-visit root canal treatment for chronic apical periodontitis.
The main questions it aims to answer are:
Do different final irrigation protocols using 17% EDTA, 9% HEDP-NaOCl, or 18% HEDP-NaOCl affect postoperative pain during the first 72 hours after root canal treatment?
Does EDDY sonic activation influence postoperative pain compared with conventional syringe irrigation?
Does the effect of the final irrigation solution on postoperative pain differ according to whether EDDY activation is applied?
Do the different final irrigation protocols affect analgesic consumption during the first 72 hours after treatment?
Do these irrigation protocols influence clinical and radiographic periapical healing at 12 months, as assessed by the Periapical Index (PAI) and fractal dimension (FD) analysis?
Participants will be randomly assigned to one of six groups before root canal treatment.
Group 1: Final irrigation with 17% EDTA using conventional syringe irrigation without sonic activation.
Group 2: Final irrigation with 17% EDTA combined with EDDY sonic activation.
Group 3: Final irrigation with 9% HEDP-NaOCl using conventional syringe irrigation without sonic activation.
Group 4: Final irrigation with 9% HEDP-NaOCl combined with EDDY sonic activation.
Group 5: Final irrigation with 18% HEDP-NaOCl using conventional syringe irrigation without sonic activation.
Group 6: Final irrigation with 18% HEDP-NaOCl combined with EDDY sonic activation.
All participants will undergo single-visit root canal treatment using the same standardized endodontic treatment protocol. Root canal preparation will be performed using reciprocating nickel-titanium instruments, followed by the assigned final irrigation protocol.
In all groups, 5 mL of the assigned final irrigation solution will be applied for 60 seconds. In the sonic activation groups, the irrigation solution will be activated using the EDDY system in three consecutive 20-second cycles. In the non-activation groups, conventional syringe irrigation will be performed for 60 seconds without sonic activation.
Postoperative pain will be assessed using a 0-10 visual analog scale (VAS) at 6, 12, 24, 48, and 72 hours after treatment. The primary outcome will be the postoperative pain trajectory across these five time points, including comparisons of pain intensity between the six irrigation protocols.
Analgesic consumption during the first 72 hours will be recorded as a secondary outcome.
Clinical follow-up examinations will be performed at 3 and 6 months, followed by clinical and radiographic evaluations at 12 months. Periapical healing will be assessed by comparing baseline and 12-month PAI scores and evaluating radiographic changes using fractal dimension analysis. Clinical signs and symptoms, including spontaneous pain, percussion and palpation sensitivity, swelling, and sinus tract formation, will also be evaluated at the 12-month follow-up.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to this group received conventional final root canal irrigation with 5 mL of 17% ethylenediaminetetraacetic acid (EDTA) for 60 seconds using a 30-gauge side-vented irrigation needle positioned 1 mm short of the working length. No sonic activation was performed. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.
Drug: 17% EDTA
Participants assigned to this group received final root canal irrigation with 5 mL of 17% ethylenediaminetetraacetic acid (EDTA) combined with EDDY sonic activation. The EDDY tip was positioned 2 mm short of the working length, and the irrigation solution was sonically activated in three consecutive 20-second cycles, providing a total activation time of 60 seconds. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.
Drug: 17% EDTA · Device: EDDY Sonic Activation
Participants assigned to this group received conventional final root canal irrigation with 5 mL of 9% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution for 60 seconds using a 30-gauge side-vented irrigation needle positioned 1 mm short of the working length. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 10 mL of 2.5% NaOCl. No sonic activation was performed. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.
Drug: 9% HEDP-NaOCl
Participants assigned to this group received final root canal irrigation with 5 mL of 9% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution combined with EDDY sonic activation. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 10 mL of 2.5% NaOCl. The EDDY tip was positioned 2 mm short of the working length, and the irrigation solution was sonically activated in three consecutive 20-second cycles, providing a total activation time of 60 seconds. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.
Drug: 9% HEDP-NaOCl · Device: EDDY Sonic Activation
Participants assigned to this group received conventional final root canal irrigation with 5 mL of 18% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution for 60 seconds using a 30-gauge side-vented irrigation needle positioned 1 mm short of the working length. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 5 mL of 2.5% NaOCl. No sonic activation was performed. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.
Drug: 18% HEDP-NaOCl
Participants assigned to this group received final root canal irrigation with 5 mL of 18% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution combined with EDDY sonic activation. The irrigation solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP in 5 mL of 2.5% NaOCl. The EDDY tip was positioned 2 mm short of the working length, and the irrigation solution was sonically activated in three consecutive 20-second cycles, providing a total activation time of 60 seconds. Following final irrigation, the root canal was flushed with 2.5 mL of distilled water, dried with sterile paper points, and obturated using AH Plus sealer and gutta-percha with the cold lateral condensation technique.
Drug: 18% HEDP-NaOCl · Device: EDDY Sonic Activation
A 17% ethylenediaminetetraacetic acid (EDTA) solution (ENDO-SOLUTION, Cerkamed, Stalowa Wola, Poland) was used as a final root canal irrigant. A total of 5 mL of the solution was applied for 60 seconds. In the conventional irrigation group, the solution was delivered using a 30-gauge side-vented irrigation needle without sonic activation. In the EDDY activation group, the solution was sonically activated using the EDDY system in three consecutive 20-second cycles, providing a total activation time of 60 seconds.
A 9% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution was used as a final root canal irrigant. The solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP (Medcem GmbH, Weinfelden, Switzerland) in 10 mL of 2.5% NaOCl. A total of 5 mL of the prepared solution was applied for 60 seconds. In the conventional irrigation group, the solution was delivered using a 30-gauge side-vented irrigation needle without sonic activation. In the EDDY activation group, the solution was sonically activated using the EDDY system in three consecutive 20-second cycles, providing a total activation time of 60 seconds.
A 18% etidronic acid (HEDP)-sodium hypochlorite (NaOCl) solution was used as a final root canal irrigant. The solution was freshly prepared immediately before use by dissolving one capsule of Dual Rinse® HEDP (Medcem GmbH, Weinfelden, Switzerland) in 5 mL of 2.5% NaOCl. A total of 5 mL of the prepared solution was applied for 60 seconds. In the conventional irrigation group, the solution was delivered using a 30-gauge side-vented irrigation needle without sonic activation. In the EDDY activation group, the solution was sonically activated using the EDDY system in three consecutive 20-second cycles, providing a total activation time of 60 seconds.
The EDDY sonic irrigation activation system (EDDY®, VDW GmbH, Munich, Germany) was used to activate the assigned final root canal irrigation solution (17% EDTA, 9% HEDP-NaOCl, or 18% HEDP-NaOCl). The EDDY tip was inserted into the root canal and positioned 2 mm short of the working length. Sonic activation was performed in three consecutive 20-second cycles, providing a total activation time of 60 seconds. A total of 5 mL of the assigned irrigation solution was used during the final irrigation procedure. Following activation, the root canal was flushed with 2.5 mL of distilled water to remove residual irrigants.
Postoperative Pain Intensity Over 72 Hours
Postoperative pain intensity was assessed using a patient-reported 0-10 visual analog scale (VAS), where 0 indicated no pain and 10 indicated unbearable pain. Pain scores were recorded at 6, 12, 24, 48, and 72 hours after completion of single-visit root canal treatment. The primary outcome was the postoperative pain trajectory across these five time points, including differences in pain intensity between the six randomized final irrigation protocols.
Time frame: 6, 12, 24, 48, and 72 hours after root canal treatment
Analgesic Consumption Within 72 Hours After Root Canal Treatment
Analgesic consumption was assessed during the first 72 hours after root canal treatment. Participants were instructed to take 400 mg ibuprofen as needed for postoperative pain and to record the timing and number of tablets consumed. Analgesic use was evaluated by recording whether participants required analgesic medication and the total number of tablets consumed during the 72-hour follow-up period.
Time frame: Within 72 hours after root canal treatment
Change in Periapical Index (PAI) Scores From Baseline to 12 Months
Periapical radiographic status was assessed using the Periapical Index (PAI), an ordinal scoring system ranging from 1 (normal periapical structures) to 5 (severe apical periodontitis with exacerbating features). Standardized periapical radiographs obtained at baseline and 12 months after root canal treatment were independently evaluated by two observers. Disagreements were resolved by consensus. Changes in PAI scores from baseline to 12 months were assessed to evaluate radiographic periapical healing across the six final irrigation protocols. Lower PAI scores indicate more favorable periapical conditions.
Time frame: Baseline and 12 months after root canal treatment
Change in Periapical Fractal Dimension (FD) From Baseline to 12 Months
Fractal dimension (FD) analysis was performed on periapical radiographs obtained at baseline and 12 months after root canal treatment to quantitatively assess changes in periapical bone trabecular pattern complexity. Standardized regions of interest were selected in corresponding anatomical areas using ImageJ software. FD values were calculated for both time points, and the change was determined by subtracting the baseline FD value from the 12-month FD value. FD changes were compared among the six final irrigation protocols. FD values were interpreted as measures of radiographic structural complexity rather than direct indicators of treatment success or failure.
Time frame: Baseline and 12 months after root canal treatment
Clinical Healing Status at 12 Months
Clinical healing was evaluated 12 months after root canal treatment based on the absence of spontaneous pain, tenderness to percussion or palpation, swelling, and sinus tract formation. Participants were classified as having achieved clinical healing when all assessed signs and symptoms were absent. The proportion of participants achieving clinical healing was evaluated across the six randomized final irrigation protocols.
Time frame: 12 months after root canal treatment
Radiographic Periapical Healing Status at 12 Months
Radiographic periapical healing was assessed by comparing baseline and 12-month periapical radiographs. Radiographic outcomes were classified into three categories: complete healing, healing in progress, and no healing or worsening. The distribution of these radiographic healing categories was evaluated across the six randomized final irrigation protocols.
Time frame: Baseline and 12 months after root canal treatment
Plan to share: No
Ran from Mar 2025 to primary completion in Aug 2025, 5 months.
Of 172 non-industry interventional studies with no phase under Periapical Periodontitis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 19. This study's 5 months is below that.
Counting every sponsor, half of 173 studies reached it within 12 months; a quarter within 6 and three quarters within 19.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.